{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:22:13Z","timestamp":1760908933005},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T00:00:00Z","timestamp":1421107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1245\/s10434-014-4263-8","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T16:46:54Z","timestamp":1421081214000},"page":"2387-2394","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Quality of Life in Platinum-Sensitive Recurrent Ovarian Cancer: Chemotherapy Versus Surgery Plus Chemotherapy"],"prefix":"10.1245","volume":"22","author":[{"given":"Francesco","family":"Plotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Luvero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Capriglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Montera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"De Cicco Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Terranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Angioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,13]]},"reference":[{"key":"4263_CR1","volume-title":"Cancer facts and figures\u00a02013","author":"American Cancer Society","year":"2013","unstructured":"American Cancer Society. Cancer facts and figures\u00a02013. Atlanta: American Cancer Society, 2013."},{"key":"4263_CR2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248\u201359.","journal-title":"J Clin Oncol."},{"issue":"Suppl","key":"4263_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","volume":"83","author":"AP Heintz","year":"2003","unstructured":"Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Gynecol Obstet. 2003;83(Suppl):135\u201366.","journal-title":"Int J Gynecol Obstet."},{"key":"4263_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","volume":"112","author":"RE Bristow","year":"2009","unstructured":"Bristow RE, Puri I, Chi DS. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol. 2009;112:265\u201374.","journal-title":"Gynecol Oncol."},{"key":"4263_CR5","first-page":"2","volume":"28","author":"T Al Rawahi","year":"2013","unstructured":"Al Rawahi T, Lopes AD, Bristow RE. Surgical cytoreduction for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev. 2013;28:2.","journal-title":"Cochrane Database Syst Rev."},{"key":"4263_CR6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2005.09.060","volume":"100","author":"R Angioli","year":"2006","unstructured":"Angioli R, Palaia I, Zullo MA, et al. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol. 2006;100:455\u201361.","journal-title":"Gynecol Oncol."},{"key":"4263_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Dematrtines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and result of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"4263_CR8","first-page":"16","volume-title":"WHO handbook for reporting results of cancer treatment (offset publication no. 48)","author":"World Health Organization","year":"1979","unstructured":"World Health Organization. WHO handbook for reporting results of cancer treatment (offset publication no. 48). Geneva: World Health Organization; 1979:16\u201321."},{"key":"4263_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0959-8049(00)00186-6","volume":"36","author":"K Bjordal","year":"2000","unstructured":"Bjordal K, deGraeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (The EORTC QLQ-H&N35). Eur J Cancer. 2000;36:213\u20139.","journal-title":"Eur J Cancer."},{"key":"4263_CR10","unstructured":"Greimel E, Bottomley A, Cull A, et al; EORTC Quality of Life Group and the Quality of Life Unit. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402\u20138. Published correction appears in Eur J Cancer. 2003;39(17):2570."},{"key":"4263_CR11","volume-title":"The EORTC QLQ_C30 scoring manual","author":"NW Scott","year":"2001","unstructured":"Scott NW, Fayers PM. The EORTC QLQ_C30 scoring manual. 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer; 2001.","edition":"3"},{"issue":"3","key":"4263_CR12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","volume":"79","author":"A Gadducci","year":"2000","unstructured":"Gadducci A, Lacconi P, Cosio S, et al. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol. 2000;79(3):344\u20139.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"4263_CR13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygyno.2004.11.057","volume":"97","author":"M Gungor","year":"2005","unstructured":"Gungor M, Ortac F, Arvas M, et al. The role of secondary cytoreductive surgery for recurrent ovarian cancer. Gynecol Oncol. 2005;97(1):74\u20139.","journal-title":"Gynecol Oncol."},{"issue":"12","key":"4263_CR14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, du Bois A, Hahmann M, et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial. Ann Surg Oncol. 2006;13(12):1702\u201310.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"4263_CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2004.09.018","volume":"95","author":"AR Munkarah","year":"2004","unstructured":"Munkarah AR, Coleman RL. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Gynecol Oncol. 2004;95(2):273\u201380.","journal-title":"Gynecol Oncol."},{"key":"4263_CR16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2006.10.020","volume":"104","author":"A Santillan","year":"2007","unstructured":"Santillan A, Karam AK, Li AJ, et al. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecol Oncol. 2007;104:686\u201390.","journal-title":"Gynecol Oncol."},{"issue":"3","key":"4263_CR17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2007.04.006","volume":"106","author":"SJ Tebes","year":"2007","unstructured":"Tebes SJ, Sayer RA, Palmer JM, et al. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol. 2007;106(3):482\u20137.","journal-title":"Gynecol Oncol."},{"key":"4263_CR18","doi-asserted-by":"crossref","unstructured":"Galaal K, Naik R, Bristow RE, et al. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev. 2010; (6).","DOI":"10.1002\/14651858.CD007822.pub2"},{"key":"4263_CR19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/IGC.0b013e31821bb8aa","volume":"21","author":"M Friedlander","year":"2011","unstructured":"Friedlander M, Trimble E, Tinker A, et al. Clinical trials in recurrent ovarian cancer. Int J Gynecol Cancer. 2011;21:771\u20135.","journal-title":"Int J Gynecol Cancer."},{"issue":"4","key":"4263_CR20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","volume":"21","author":"GC Stuart","year":"2011","unstructured":"Stuart GC, Kitchener H, Bacon M, et al. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int J Gynecol Cancer. 2011;21(4):750\u20135.","journal-title":"Int J Gynecol Cancer."},{"issue":"16","key":"4263_CR21","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1200\/JCO.2003.99.034","volume":"21","author":"D Cella","year":"2003","unstructured":"Cella D. What do global quality-of-life questions really measure? Insights from Hobday et al and the \u201cdo something\u201d rule. J Clin Oncol. 2003;21(16): 3178\u20139.","journal-title":"J Clin Oncol."},{"issue":"2","key":"4263_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00435734","volume":"2","author":"WHO","year":"1993","unstructured":"WHO. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res. 1993;2(2):153\u20139.","journal-title":"Qual Life Res."},{"issue":"3","key":"4263_CR23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IGC.0b013e3182842fc4","volume":"23","author":"R Angioli","year":"2013","unstructured":"Angioli R, Plotti F, Aloisi A, et al. Does extensive upper abdomen surgery during primary cytoreduction impact on long-term quality of life? Int J Gynecol Cancer. 2013;23(3):442\u20137.","journal-title":"Int J Gynecol Cancer."},{"issue":"2","key":"4263_CR24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejogrb.2013.07.037","volume":"170","author":"R Angioli","year":"2013","unstructured":"Angioli R, Plotti F, Caf\u00e0 EV, et al. Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):539\u201343.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"4263_CR25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0959-8049(97)00049-X","volume":"33","author":"A Coates","year":"1997","unstructured":"Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer. 1997;33:1025\u201330.","journal-title":"Eur J Cancer."},{"key":"4263_CR26","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1200\/JCO.2003.07.128","volume":"21","author":"D Eton","year":"2003","unstructured":"Eton D, Fairclough D, Cella D, et al. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol. 2003;21:1536\u201343.","journal-title":"J Clin Oncol."},{"key":"4263_CR27","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1200\/JCO.1992.10.12.1833","volume":"10","author":"A Coates","year":"1992","unstructured":"Coates A, Gebski V, Signorini D, et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer: Australian New Zealand Breast Cancer Trials Group. J Clin Oncol. 1992;10:1833\u20138.","journal-title":"J Clin Oncol."},{"key":"4263_CR28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1026442201191","volume":"6","author":"J Dancey","year":"1997","unstructured":"Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. Qual Life Res 1997;6:151\u20138.","journal-title":"Qual Life Res"},{"key":"4263_CR29","first-page":"17","volume":"91","author":"PH Sugarbaker","year":"1982","unstructured":"Sugarbaker PH, Barofsky I, Rosenberg SA, et al. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery. 1982;91:17\u201323.","journal-title":"Surgery."},{"key":"4263_CR30","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1200\/JCO.2005.05.2951","volume":"24","author":"JM Blazeby","year":"2006","unstructured":"Blazeby JM, Avery K, Sprangers M, et al. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol. 2006;24:3178\u201386.","journal-title":"J Clin Oncol."},{"issue":"6","key":"4263_CR31","first-page":"672","volume":"31","author":"M Zamurovic","year":"2010","unstructured":"Zamurovic M. Ovarian carcinoma patients\u2013life quality analysis in the postoperative period. How to improve it? Eur J Gynaecol Oncol. 2010;31(6):672\u20134.","journal-title":"Eur J Gynaecol Oncol."},{"key":"4263_CR32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejso.2010.04.012","volume":"36","author":"L Woelber","year":"2010","unstructured":"Woelber L, Jung S, Eulenburg C, et al. Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer. Eur J Surg Oncol. 2010;36:583\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"4263_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2008.11.011","volume":"112","author":"F Vernooij","year":"2009","unstructured":"Vernooij F, Heintz AP, Coebergh JW, et al. Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol. 2009;112:455\u201361.","journal-title":"Gynecol Oncol."},{"key":"4263_CR34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2010.05.025","volume":"118","author":"RE Bristow","year":"2010","unstructured":"Bristow RE, Palis BE, Chi DS, et al. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol. 2010;118:262\u20137.","journal-title":"Gynecol Oncol."},{"key":"4263_CR35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","volume":"21","author":"P Harter","year":"2011","unstructured":"Harter P, Sehouli J, Reuss A, et al. Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. Int J Gynecol Cancer. 2011;21:289\u201395.","journal-title":"Int J Gynecol Cancer."},{"key":"4263_CR36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","volume":"19","author":"WJ Tian","year":"2012","unstructured":"Tian WJ, Chi DS, Sehouli J, et al. A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection. Ann Surg Oncol. 2012;19:597\u2013604.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4263-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4263-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4263-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T15:27:48Z","timestamp":1566228468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4263-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,13]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["4263"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4263-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,13]]}}}